Alkermes plc reiterated earnings guidance for the year 2024. The company reiterates its financial expectations for 2024, as set forth in its press release dated Feb. 15, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.18 USD | -1.83% |
|
-0.98% | -12.83% |
06-17 | TD Cowen Initiates Alkermes at Buy With $34 Price Target | MT |
06-11 | Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.83% | 4.09B | |
+38.36% | 52.73B | |
+38.54% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Alkermes plc Reiterates Earnings Guidance for the Year 2024